Vivian Emmely Golfin, MD
Senior Investor, Corporate Strategy
San Francisco Bay Area · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
Dr Vivian Emmely de Ruijter is a venture capitalist and Stanford University trained physician in healthcare technology innovation. As an investor at Intuitive Ventures she invests in products and services that advance the future of minimally invasive care with an emphasis on digital products/services, focal therapeutics, medical devices and precision diagnostics. Prior to her current role, she served as a senior manager of the Digital and Healthcare Technology Strategy Group at Manatt, Phelps and Phillips where she provided expertise and interpretation to strategic healthcare technology initiatives and how to navigate the nuances of bringing products to market. Dr. de Ruijter also served as a life science technology innovation scientist at Stanford University and the Co-Director of the Stanford Pediatric Device Consortium in collaboration with the U.S. FDA. She was the 2016 Gruber’s Innovation Fellow at Byer’s Center of Biodesign at Stanford University after completing her training in hybrid interventional strategies at the IRCAD in France. Dr de Ruijter holds a Doctor of Medicine (MD) degree from The Erasmus University in the Netherlands, a post-doctoral designation in Biodesign,
Experience
May 2019 to Jul 2021
Sep 2018 to Jul 2021
Sep 2017 to Jan 2020
Education
Stanford Ignite
2015 to 2015
Propaedeutics and Doctoral degree (MD) Medicine
2006 to 2014
MD Institute of Health, Policy & Management
2010 to 2010
Fellowship Minimally Invasive Surgery and Medical Device Development
2010 to 2014
Minimally Invasive Surgery
2010 to 2012